Correlation Between Anebulo Pharmaceuticals and Medpace Holdings

Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and Medpace Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and Medpace Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Anebulo Pharmaceuticals and Medpace Holdings, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and Medpace Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of Medpace Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and Medpace Holdings.

Diversification Opportunities for Anebulo Pharmaceuticals and Medpace Holdings

0.16

Correlation Coefficient

Anebulo Pharmaceuticals  Medpace Holdings

Average diversification

The 3 months correlation between Anebulo and Medpace is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and Medpace Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medpace Holdings and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with Medpace Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medpace Holdings has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and Medpace Holdings go up and down completely randomly.

Pair Corralation between Anebulo Pharmaceuticals and Medpace Holdings

Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to generate 2.03 times less return on investment than Medpace Holdings. In addition to that, Anebulo Pharmaceuticals is 2.57 times more volatile than Medpace Holdings. It trades about 0.01 of its total potential returns per unit of risk. Medpace Holdings is currently generating about 0.05 per unit of volatility. If you would invest  20,828  in Medpace Holdings on September 21, 2024 and sell it today you would earn a total of  12,687  from holding Medpace Holdings or generate 60.91% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Anebulo Pharmaceuticals  vs.  Medpace Holdings

Anebulo Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Anebulo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's technical and fundamental indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Medpace Holdings

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Medpace Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental indicators, Medpace Holdings is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Anebulo Pharmaceuticals and Medpace Holdings

The main advantage of trading using opposite Anebulo Pharmaceuticals and Medpace Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, Medpace Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medpace Holdings will offset losses from the drop in Medpace Holdings' long position.

The idea behind Anebulo Pharmaceuticals and Medpace Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.